![](/img/cover-not-exists.png)
P-572 Phase I–II trial of TLK286 (telcyta), carboplatin (C), and paclitaxel(P) as first-line treatment for advanced non-small cell lung cancer (NSCLC)
Seguist, L., Fidias, P., Temel, J., Kennedy, E., Ostler, P., Rabin, M., Huberman, M., Keck, J., Brown, G., Lynch, T.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81065-7
Date:
July, 2005
File:
PDF, 328 KB
english, 2005